B

Braxia Scientific
BRAX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CA$1.42M
EV
CA$1.92M
Shares Outstanding
283.28M
Beta
1.38
Industry
Biotechnology

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2024E
-
P/Revenue 2024E
-

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2024E
-
Net Profit Margin 2024E
-
ROE 2024E
-
ROCE 2023
-248.72%

Dividends

DPS 2024E
-
Payout Ratio 2024E
-
Div. Yield 2024E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Braxia Scientific Corp.

gainify

B

Braxia Scientific Corp.

BRAX

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorder...

Sector

Healthcare

Industry

Biotechnology

CEO

Data Unavailable

Employees

IPO Date

2020-03-02

Headquarters

700 Bay Street, Suite 1903, Toronto, Ontario, M5G 1Z6, Canada

📊 Stock Price & Performance

The last closing price of Braxia Scientific (BRAX) is CA$0.01, reflecting a +0.00% change from the prior session. Last updated: December 31, 2025 at 4:03 PM Eastern Time

Review the recent BRAX stock performance trends:Past 1 Month: Braxia Scientific (BRAX) shares have +0.00%.Past 3 Months: The stock has -50.00%.Past 6 Months: BRAX shares have -50.00%. Last updated: December 31, 2025 at 11:42 PM Eastern Time

Over the last year, Braxia Scientific (BRAX) has established a 52-week price range between a high of CA$0.01 and a low of CA$0.01. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:42 PM Eastern Time

Braxia Scientific (BRAX) is considered a medium volatility stock. It has a beta of 1.38, which means it typically moves 1.38 times as much as the broader market. Over the past 52 weeks, BRAX has traded within a CA$0.01 – CA$0.01 range. Last updated: December 31, 2025 at 11:42 PM Eastern Time

A CA$1,000 investment in Braxia Scientific 5 years ago, when the stock was trading around CA$0.44, would be worth approximately CA$22.74 today, based solely on share price performance (excluding dividends). This represents a total return of -97.73% over the period, equivalent to a compound annual growth rate (CAGR) of -53.08%. Past performance reflects historical price movements only and does not imply future results. Last updated: December 31, 2025 at 11:42 PM Eastern Time

💰 Financial Metrics & Reports

The current Braxia Scientific (BRAX) market capitalization is approximately CA$1.42M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Braxia Scientific's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:42 PM Eastern Time

In the most recently reported quarter, Braxia Scientific (BRAX) generated CA$492.45K in revenue, representing a +0.71% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 2:23 AM Eastern Time

In the most recently reported fiscal year, Braxia Scientific (BRAX) generated net income of CA$-13.14M, compared with CA$-12.13M in the prior fiscal year, representing a -8.30% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 2:23 AM Eastern Time

According to its latest quarterly filing, Braxia Scientific (BRAX) reported EBITDA of CA$-0.81M, representing a +63.11% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 2:23 AM Eastern Time

Based on the latest available data, Braxia Scientific (BRAX) is currently trading at a last twelve months (LTM) P/E ratio of -0.13x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 2:23 AM Eastern Time

📅 Earnings & Dividends

In the most recently reported quarter, Braxia Scientific (BRAX) revenue was CA$492.45K. Earnings per share (EPS) for the quarter were CA$-0.00. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 2:23 AM Eastern Time

Braxia Scientific (BRAX) does not currently pay a dividend. Over the last twelve months (LTM), the company paid CA$0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: January 1, 2026 at 2:23 AM Eastern Time

📈 Analyst Information

Based on the latest available analyst coverage, Braxia Scientific (BRAX) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 2:23 AM Eastern Time

Like other publicly traded stocks, Braxia Scientific (BRAX) shares are bought and sold on stock exchanges such as CNSX and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Braxia Scientific (BRAX) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add BRAX to your watchlist.

Braxia Scientific trades under the ticker symbol BRAX on the CNSX stock exchange. The ticker BRAX is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

Braxia Scientific (BRAX) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Braxia Scientific (BRAX) stock peers based on overlapping products, services, and competitive dynamics:Numinus Wellness (NUMI) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Braxia Scientific.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.